Full name
MEDICOVER INTEGRATED CLINICAL SERVICES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
72.19.Z - Scientific research and development activities
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -62,5 | |||
Gross profit (loss) | -0,8 | -5 | -4 | 19,8 |
EBITDA | -0,4 | 5,8 | 9,3 | 59,1 |
Short time liabilities | 3,8 | 32,7 | 75,5 | 130,8 |
Other operating costs | -59 | |||
Equity capital | 3,2 | -1,8 | 0,4 | 124 |
Operating profit (EBIT) | -0,6 | -2,2 | -0,1 | 96,3 |
Assets | 8,2 | 91,8 | 80,4 | -12,4 |
Net profit (loss) | -0,8 | -5 | -3,6 | 27,4 |
Cash | 0 | 0 | 0,1 | 136 |
Liabilities and provisions for liabilities | 5 | 93,6 | 80 | -14,5 |
Net income from sale | 32,7 | 49,6 | 53,5 | 7,9 |
Working assets | 7,2 | 21,9 | 28,7 | 31,4 |
Other income costs | 214 317,7 | |||
Depreciation | 0,2 | 8 | 9,4 | 16,6 |
% | % | % | p.p. | |
Profitability of capital | -26,1 | 278,3 | -841,4 | -1119,7 |
Equity capital to total assets | 39 | -1,9 | 0,5 | 2,4 |
Gross profit margin | -2,5 | -10 | -7,5 | 2,5 |
EBITDA Margin | -1,3 | 11,8 | 17,3 | 5,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 241 | 515 | 274 |
Current financial liquidity indicator | 0.63471919298172 | 0.3673691749572754 | -0,2 | |
Net dept to EBITDA | 10.147506713867188 | 6.9799041748046875 | -3,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane